Hutchin Hill Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-13,000
Closed -$258K 782
2016
Q3
$258K Buy
+13,000
New +$227K 0.01% 544
2016
Q2
Sell
-24,100
Closed -$374K 638
2016
Q1
$374K Buy
24,100
+7,100
+42% +$102K 0.01% 546
2015
Q4
$293K Buy
17,000
+3,300
+24% +$47.8K 0.01% 558
2015
Q3
$167K Buy
+13,700
New +$176K 0.01% 551

Other funds holding LMAT

Hutchin Hill Capital's LMAT Position: Q4 2016 in Review

Hutchin Hill Capital sold out of LeMaitre Vascular (LMAT) in Q4 2016, closing a stake of 13,000 shares — an estimated $258K sold.

Hutchin Hill Capital first reported a position in LMAT in Q3 2015 and held it in 4 quarters. The position peaked at $374K in Q1 2016. 112 funds tracked by Wall St. Rank hold LMAT as of Q4 2016.

  • Hutchin Hill Capital reported no remaining LeMaitre Vascular position as of Q4 2016 after selling out during the quarter.
  • Hutchin Hill Capital sold 13,000 LeMaitre Vascular shares in Q4 2016, an estimated $258K.
  • Hutchin Hill Capital first reported a position in LeMaitre Vascular in Q3 2015 and held it in 4 quarters.
  • Hutchin Hill Capital's LeMaitre Vascular position peaked at $374K in Q1 2016.
  • 112 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2016.

Based on Hutchin Hill Capital's 13F filing for Q4 2016, filed 14 Feb 2017.